In the case of cerebral ischemia, OX1R mediated the MAPK/ERK/mechanistic target of the rapamycin (mTOR) pathway to inhibit excessive autophagy via orexin-A, leading to increased cellular viability [36]. The gene discussed is HCRT; the disease is brain ischemia.